Clinical Report: Predictive Model for Anti-TNF-α Treatment in Crohn’s Disease

Overview

This study develops a predictive model utilizing choroid plexus imaging from brain MRI to evaluate responses to anti-TNF-α therapy in Crohn's disease. The findings suggest that alterations in the choroid plexus may serve as biomarkers for predicting treatment outcomes.

Background

Crohn's disease (CD) is a chronic inflammatory bowel disease with rising global incidence and significant morbidity. Anti-TNF-α therapies are pivotal in managing moderate to severe CD, yet patient responses vary widely, necessitating reliable predictive tools. Understanding the relationship between central nervous system alterations and CD may enhance treatment personalization.

Data Highlights

No numerical data provided in the article.

Key Findings

• Choroid plexus imaging may provide biomarkers for predicting anti-TNF-α therapy responses.
• Approximately 10-20% of patients show primary non-response to anti-TNF-α therapy.
• Secondary loss of response occurs in 23-46% of patients within one year of treatment initiation.
• Changes in choroid plexus volume and permeability correlate with systemic inflammatory markers in CD.
• The study highlights the need for clinically applicable predictive tools for anti-TNF-α therapy.

Clinical Implications

The integration of choroid plexus imaging into clinical practice may improve the prediction of treatment responses in Crohn's disease patients. This could lead to more personalized treatment strategies and potentially reduce the economic burden associated with ineffective therapies.

Conclusion

The findings underscore the potential of choroid plexus imaging as a novel biomarker for predicting anti-TNF-α treatment responses in Crohn's disease, paving the way for enhanced patient management.

References

1. European Radiology, 2023 -- Association of Radiologic Findings with Infliximab Response in Treatment-Naïve Patients with Crohn’s Disease
2. Journal of Crohn's and Colitis, 2023 -- Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use
3. Journal of Crohn's and Colitis, 2023 -- Real-world evaluation of MRI fistula volume as a radiological biomarker of disease activity in perianal fistulizing Crohn’s disease
4. Journal of Crohn's and Colitis, 2023 -- ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response
5. ACG, 2025 -- ACG Clinical Guideline: Management of Crohn's Disease
6. American Gastroenterological Association -- Pharmacological management of moderate-to-severe Crohn’s disease
7. ECCO, 2025 -- New ECCO Guidelines on Opportunistic Infections in IBD – 2025 Update
8. PubMed -- IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled Trials
9. PubMed -- The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring
10. PubMed -- The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease
11. Fluids and Barriers of the CNS -- Choroid plexus volume in brain disorders: a systematic review
12. Official journal of the American College of Gastroenterology | ACG
13. Pharmacological management of moderate-to-severe Crohn’s disease - American Gastroenterological Association
14. New ECCO Guidelines on Opportunistic Infections in IBD – 2025 Update - ECCO - European Crohn’s and Colitis Organisation
15. IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled Trials - PubMed
16. The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring - PubMed
17. The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease - PubMed
18. Choroid plexus volume in brain disorders: a systematic review | Fluids and Barriers of the CNS | Full Text